metoprolol and digoxin
metoprolol has been researched along with digoxin in 55 studies
Research
Studies (55)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (16.36) | 18.7374 |
| 1990's | 3 (5.45) | 18.2507 |
| 2000's | 22 (40.00) | 29.6817 |
| 2010's | 15 (27.27) | 24.3611 |
| 2020's | 6 (10.91) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Artursson, P; Neuhoff, S; Ungell, AL; Zamora, I | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Avigliano, M; Carbajo, R; Crutcher, P; Morozzi, C; Pertusati, F; Sandoval, L; Sedláková, J; Serpi, M; Thomas, S; Valles-Ayoub, Y | 1 |
| Bukhari, S; Cabral, AD; de Araujo, ED; Gawel, JM; Gunning, PT; He, L; Johns, AE; Manaswiyoungkul, P; Nawar, N; Olaoye, OO; Raouf, YS; Sedighi, A; Shouksmith, AE; Sina, D | 1 |
| Becker, A; Georg, GI; Hong, KH; Lee, JC; Schönbrunn, E; Tash, JS | 1 |
| Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
| Ahuja, VT; Allen, J; Bristow, LJ; Bronson, JJ; Brown, JM; Camac, D; Dandapani, K; Dokania, M; Dzierba, CD; Easton, A; Elavazhagan, S; Gulianello, M; Hamman, BD; Hartz, RA; Hunihan, L; Kiefer, SE; Kostich, W; Kumar, CMV; Lewis, M; Lippy, JS; Macor, JE; Muckelbauer, JK; Nara, SJ; Pattipati, SN; Rajamani, R; Surti, N | 1 |
| Edvardsson, N; Hirsch, I; Olsson, SB | 2 |
| Ahuja, RC; Hasan, M; Jain, AK; Saran, RK; Sinha, N | 1 |
| Plunkett, LM; Tackett, RL | 1 |
| Alderman, MH; Marantz, PR; Tobin, JN | 1 |
| Caldwell, RW; Nash, CB | 1 |
| Cleland, LG; James, DW; Leonello, PP; Robinson, CW | 1 |
| Hjalmarson, A; Swedeberg, K; Waagstein, F; Wallentin, I | 1 |
| Davoli, E; Hepner, SI | 1 |
| Goldstein, S; Gupta, RC; Kono, T; Levine, TB; Sabbah, HN; Scicli, G; Sharov, VG; Shimoyama, H | 1 |
| McMullan, MR; Moore, CK; O'Connell, JB | 1 |
| Matjasko, J; Roitman, K; Sprung, J; Wallace, M | 1 |
| Igoumenidis, NE; Kalebubas, MD; Kanoupakis, EM; Kochiadakis, GE; Mavrakis, HE; Vardakis, KE; Vardas, PE | 1 |
| Catav, Z; Gunaydin, S; Kandemir, O; Tokmakoglu, H; Yorgancioglu, C; Zorlutuna, Y | 1 |
| Aoki, S; Arao, T; Fuke, C; Hishida, S; Kamamoto, T; Kinoshita, H; Komeda, M; Kubota, A; Minami, T; Miyazaki, T; Motomura, H; Nishiguchi, M; Ohta, T; Ouchi, H; Taniguchi, T; Tsuda, T; Utsumi, T | 1 |
| Baker, J; Chauhan, V; Damle, R; Fain, E; Mazuz, M; O'Neill, PG; Ross, T; Sharma, AD; Skadsen, A; Zhang, Z | 1 |
| Bass, EB; Tamariz, LJ | 1 |
| Kowey, PR | 1 |
| Frat, JP; Robert, R; Rouffineau, J; Veinstein, A | 1 |
| Krishnan, SC; Kummer, JL; Nair, R | 1 |
| Fan, Q; Hou, YP; Liu, MB; Wu, JL; Yin, BL; Zhang, L | 1 |
| Baskurt, M; Kaya, A; Kucukoglu, S; Okcun, B; Ortak, K; Yigit, Z; Yildiz, A | 1 |
| Lee, R; Lee, T | 1 |
| Gałczyński, K; Kimber-Trojnar, Z; Kudlicki, J; Leszczyńska-Gorzelak, B; Marciniak, B; Oleszczukz, J | 1 |
| Dennis, AT; Gerstman, MD | 1 |
| Das, B; Kang, J | 1 |
| Carroll, C; Hassanin, A | 1 |
| Bedak, O; Begic, E; Bradaric, H; Custovic, F; Durak-Nalbantic, A; Hodzic, E; Mujakovic, A; Prnjavorac, B; Zvizdic, F | 1 |
| Ibrahim, J; Peterschmitt, MJ; Puga, AC; Ross, L; Thibault, N; Turpault, S; Vu, L; Xue, Y | 1 |
| Burghgraef, E; de Ruiter, ML; Mulder, FEM; Peters, RHJ | 1 |
Reviews
5 review(s) available for metoprolol and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Diagnostic heterogeneity in clinical trials for congestive heart failure.
Topics: Amrinone; Clinical Trials as Topic; Digoxin; Heart Failure; Humans; Hydralazine; Metoprolol; Research Design | 1988 |
Pharmacological rate control of atrial fibrillation.
Topics: Amiodarone; Atenolol; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Diltiazem; Heart Rate; Humans; Metoprolol; Randomized Controlled Trials as Topic; Verapamil | 2004 |
A review of carvedilol arrhythmia data in clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Digoxin; Heart Failure; Humans; Metoprolol; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic | 2005 |
[Electrical cardioversion in the treatment of cardiac arrhythmias during pregnancy--case report and review of literature].
Topics: Adult; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Digoxin; Electric Countershock; Female; Heart Rate, Fetal; Humans; Metoprolol; Pregnancy; Pregnancy Complications, Cardiovascular; Thromboembolism; Warfarin | 2013 |
Trials
7 trial(s) available for metoprolol and digoxin
| Article | Year |
|---|---|
Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study.
Topics: Adult; Arrhythmia, Sinus; Atrial Fibrillation; Digoxin; Heart Rate; Humans; Metoprolol; Mitral Valve Stenosis; Random Allocation; Verapamil | 1989 |
Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Circadian Rhythm; Cross-Over Studies; Digoxin; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Rate; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Single-Blind Method; Sotalol | 2001 |
Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Digoxin; Drug Therapy, Combination; Female; Humans; Male; Metoprolol; Middle Aged; Postoperative Complications; Prospective Studies | 2002 |
Shock on T versus direct current voltage for induction of ventricular fibrillation: a randomized prospective comparison.
Topics: Amiodarone; Defibrillators, Implantable; Digoxin; Electric Countershock; Female; Humans; Lidocaine; Male; Metoprolol; Middle Aged; Prospective Studies; Ventricular Fibrillation | 2004 |
Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Biomarkers; Cardiotonic Agents; Digoxin; Diuretics; Drug Therapy, Combination; Exercise Test; Fas Ligand Protein; fas Receptor; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Prospective Studies; Severity of Illness Index; Ultrasonography; Ventricular Function, Left | 2007 |
Comparison of rate and rhythm control in hypertension patients with atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Calcium Channel Blockers; Cardiotonic Agents; Digoxin; Electric Countershock; Female; Follow-Up Studies; Humans; Hypertension; Losartan; Male; Metoprolol; Middle Aged; Survival Analysis; Treatment Outcome; Verapamil | 2008 |
Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents.
Topics: Adolescent; Adult; Contraceptives, Oral; Cross-Over Studies; Digoxin; Drug Interactions; Female; Humans; Male; Metoprolol; Middle Aged; Proton Pump Inhibitors; Pyrrolidines; Young Adult | 2020 |
Other Studies
43 other study(ies) available for metoprolol and digoxin
| Article | Year |
|---|---|
pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Digoxin; Drug Interactions; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of
Topics: Animals; Caco-2 Cells; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Distal Myopathies; Dose-Response Relationship, Drug; Drug Delivery Systems; Hexosamines; Humans; Molecular Structure; N-Acetylneuraminic Acid; Phosphotransferases (Alcohol Group Acceptor); Prodrugs; Structure-Activity Relationship; Sugar Phosphates | 2019 |
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.
Topics: | 2020 |
Tetrahydroindazole inhibitors of CDK2/cyclin complexes.
Topics: Binding Sites; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indazoles; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship | 2021 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Caco-2 Cells; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Molecular Structure; Neuralgia; Protein Kinases; Protein Serine-Threonine Kinases; Structure-Activity Relationship | 2021 |
Effects of lidocaine, procainamide, metoprolol, digoxin and atropine on the conduction of premature ventricular beats in man.
Topics: Action Potentials; Adult; Anti-Arrhythmia Agents; Atropine; Cardiac Complexes, Premature; Digoxin; Electric Stimulation; Electrophysiology; Humans; Lidocaine; Male; Metoprolol; Procainamide | 1985 |
The effects of central beta-receptor antagonism on digoxin cardiotoxicity.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Digoxin; Dogs; Dose-Response Relationship, Drug; Female; Heart; Heart Rate; Lidocaine; Male; Metoprolol; Propanolamines; Receptors, Adrenergic, beta | 1985 |
Effect of an aminocardenolide and digoxin upon atrioventricular refractory period in the dog.
Topics: Animals; Atrioventricular Node; Atropine; Digitoxigenin; Digoxin; Dogs; Female; Heart Conduction System; Male; Metoprolol; Neural Conduction; Pressoreceptors; Refractory Period, Electrophysiological; Sympathectomy | 1985 |
Reversible renal failure: associated with treatment with a beta-adrenergic receptor blocking drug and non-steroidal anti-inflammatory drugs.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Coronary Disease; Digoxin; Female; Humans; Hypertension, Renal; Indomethacin; Male; Metoprolol; Middle Aged; Penicillamine | 1982 |
Acute effects of lignocaine, procainamide, metoprolol, digoxin and atropine on human myocardial refractoriness.
Topics: Action Potentials; Adult; Anti-Arrhythmia Agents; Atropine; Digoxin; Heart; Heart Rate; Heart Ventricles; Humans; Lidocaine; Male; Metoprolol; Procainamide; Time Factors; Ventricular Function | 1984 |
Beta-blockers in dilated cardiomyopathies: they work.
Topics: Administration, Oral; Adult; Aged; Digoxin; Dilatation, Pathologic; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Lactates; Male; Metoprolol; Middle Aged; Myocardium; Oxygen Consumption; Propanolamines; Spironolactone; Time Factors | 1983 |
Successful treatment of supraventricular tachycardia with metoprolol, a cardioselective beta blocker.
Topics: Bronchial Spasm; Digoxin; Drug Therapy, Combination; Female; Humans; Infant; Metoprolol; Propanolamines; Propranolol; Sleep Wake Disorders; Tachycardia, Paroxysmal | 1983 |
Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
Topics: Animals; Digoxin; Dilatation, Pathologic; Dogs; Enalapril; Metoprolol; Myocardium; Stroke Volume; Time Factors; Ventricular Function, Left | 1994 |
Diagnosis and management of peripartum cardiomyopathy.
Topics: Adult; Algorithms; Captopril; Cardiomyopathies; Diagnosis, Differential; Digoxin; Drug Administration Schedule; Female; Furosemide; Humans; Metoprolol; Postpartum Period; Prognosis | 1993 |
Enhancement of bupivacaine cardiotoxicity with cardiac glycosides and beta-adrenergic blockers: a case report.
Topics: Aged; Bupivacaine; Digoxin; Drug Interactions; Female; Heart; Humans; Intercostal Nerves; Metoprolol; Nerve Block; Pain, Postoperative | 1993 |
An autopsy case of combined drug intoxication involving verapamil, metoprolol and digoxin.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Drug Overdose; Humans; Male; Metoprolol; Suicide; Verapamil | 2003 |
Protective effect of medication bezoar after a massive beta-blocker, digoxin, and amitriptyline poisoning.
Topics: Administration, Oral; Adult; Amitriptyline; Bezoars; Charcoal; Digoxin; Emergency Medical Services; Female; Gastric Lavage; Gastroscopy; Hospitalization; Humans; Intensive Care Units; Metoprolol; Psychiatric Department, Hospital; Radiography; Self Administration; Stomach; Vomiting | 2005 |
Images in cardiovascular medicine. Bidirectional ventricular tachycardia caused by digitalis toxicity.
Topics: Acute Kidney Injury; Aged; Atrial Fibrillation; Bundle-Branch Block; Digitalis; Digoxin; Electrocardiography; Humans; Male; Metoprolol; Tachycardia, Ventricular | 2006 |
My wife suffers from atrial fibrillation. She is on warfarin, digoxin and metoprolol. She still gets the occasional mild attack. Is this normal?
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Digoxin; Humans; Metoprolol; Quality of Life; Treatment Failure; Warfarin | 2007 |
I have atrial fibrillation and take warfarin, digoxin and metoprolol. I still get an occasional mild attack, however. Is this normal?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Digoxin; Humans; Metoprolol; Treatment Failure; Warfarin | 2009 |
Ask the doctors. I have had atrial fibrillation for a year, and I have felt pretty normal on a beta blocker (metoprolol) and digoxin. However, I recently began to feel very fatigued and noticed my heart rate was only 35 beats per minute. We stopped tho
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Digoxin; Dose-Response Relationship, Drug; Heart Rate; Humans; Metoprolol | 2012 |
Management of labour and delivery in a woman with refractory supraventricular tachycardia.
Topics: Adult; Amides; Amnion; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Anti-Arrhythmia Agents; Delivery, Obstetric; Digoxin; Dyspnea; Echocardiography; Fatigue; Female; Fentanyl; Flecainide; Humans; Labor, Obstetric; Metoprolol; Oximetry; Oxytocics; Oxytocin; Pregnancy; Pregnancy Complications, Cardiovascular; Ropivacaine; Tachycardia, Supraventricular | 2014 |
Emergent presentation of decompensated mitral valve prolapse and atrial septal defect.
Topics: Abdominal Pain; Anticoagulants; Anxiety; Cardiotonic Agents; Continuous Positive Airway Pressure; Digoxin; Dopamine; Dyspnea; Electrocardiography; Emergencies; Heart Septal Defects, Atrial; Heart Valve Prosthesis Implantation; Humans; Male; Metoprolol; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Prolapse; Treatment Outcome; Warfarin | 2015 |
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atorvastatin; Atrial Fibrillation; Bone Density Conservation Agents; Deprescriptions; Digoxin; Diltiazem; Diuretics; Drug Overdose; Factor Xa Inhibitors; Female; Furosemide; Heart Failure; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Lisinopril; Loratadine; Metoprolol; Polypharmacy; Pyrazoles; Pyridones; Ranitidine; Syncope | 2017 |
Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Case-Control Studies; Digoxin; Disease Progression; Forced Expiratory Volume; Humans; Metoprolol; Nebivolol; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Verapamil; Vital Capacity | 2019 |
[A pregnant woman with de novo atrial fibrillation].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Female; Heart Atria; Humans; Metoprolol; Pregnancy; Pregnant Women | 2023 |